2017
DOI: 10.1016/j.yrtph.2017.09.027
|View full text |Cite
|
Sign up to set email alerts
|

Citrus aurantium (bitter orange) extract: Safety assessment by acute and 14-day oral toxicity studies in rats and the Ames Test for mutagenicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 18 publications
(18 citation statements)
references
References 17 publications
0
18
0
Order By: Relevance
“…For the sake of comparison, it should be noted that the oral LD50 of sodium chloride, common table salt, is about 3000 mg/kg. The oral administration of a 50% p-synephrine bitter orange extract at a dose of 2000 mg/kg to female rats for four consecutive days did not have any toxicological effects (Deshmukh et al, 2017a), while a dose of 1000 mg/kg for 90 days produced no deaths or serious adverse effects (Deshmukh et al, 2017b). The animals exhibited burrowing of the heads in the bedding material and piloerection, which disappeared by the end of the study.…”
Section: Animal Studiesmentioning
confidence: 89%
See 2 more Smart Citations
“…For the sake of comparison, it should be noted that the oral LD50 of sodium chloride, common table salt, is about 3000 mg/kg. The oral administration of a 50% p-synephrine bitter orange extract at a dose of 2000 mg/kg to female rats for four consecutive days did not have any toxicological effects (Deshmukh et al, 2017a), while a dose of 1000 mg/kg for 90 days produced no deaths or serious adverse effects (Deshmukh et al, 2017b). The animals exhibited burrowing of the heads in the bedding material and piloerection, which disappeared by the end of the study.…”
Section: Animal Studiesmentioning
confidence: 89%
“…There are no indications that p-synephrine adversely affects the heart, liver, kidneys, or thyroid at doses up to 100 mg per day (Stohs et al, 2012;Kaats et al, 2013;Shara et al, 2016;Kaats and Stohs, 2017), and as a consequence, there is no evidence supporting the proposed contraindications. Furthermore, studies have shown that no teratogenicity (Hansen et al, 2011) or mutagenicity (Morimoto et al, 1982;Kaefer, 2014;Deshmukh et al, 2017a) occurs in response to p-synephrine and bitter orange extracts. However, some cautionary statements regarding use of bitter orange extract and p-synephrine may be warranted and are subject to further discussions.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although bitter orange extracts are now extensively used in dietary supplements and p -synephrine occurs in various Citrus juices and food products, subchronic safety studies on this extract and p -synephrine have not been conducted. It has been previously shown that the oral LD50 of a bitter orange extract standardized to 50% p -synephrine exceeded 5000 mg/kg in female rats [4] , indicating a high degree of safety. Oral administration of this extract at 2000 mg/kg to female rats for four consecutive days did not produce any overt signs of toxicity [4] .…”
Section: Introductionmentioning
confidence: 96%
“…It has been previously shown that the oral LD50 of a bitter orange extract standardized to 50% p -synephrine exceeded 5000 mg/kg in female rats [4] , indicating a high degree of safety. Oral administration of this extract at 2000 mg/kg to female rats for four consecutive days did not produce any overt signs of toxicity [4] .…”
Section: Introductionmentioning
confidence: 96%